Dr. Valery Uhl - Review of 'scientific validation' of the TARGIT-A long-term outcomes

Share this video


Dr. Valery Uhl

Board Certified Radiation Oncologist trained at UCSF, San Francisco, USA and President of the TARGIT Collaborative Group (TCG) Society


Summary

President of the TCG talking about the TARGIT-A outcomes from the perspective of an American radiation oncologist

In this recorded clinical webinar Dr. Valery Uhl is presenting the recently published 8.6 years results of the TARGIT-A study on breast cancer from her perspective as a radiation oncologist and the president of the TCG. Overall, Dr. Uhl is highlighting the aspect of scientific validation but also gives some insights about clinical effectiveness and treatment efficiency.


To view, please login or register. MyZEISS is your gateway to all digital offerings from ZEISS.

  • Gain full access to clinical insights from peers. 
  • Access latest training and learning content for you and your team. 
  • Get quick access to tools and documents. 


Share this video


Related articles